Aveanna Healthcare Holdings, INC Form 4 insider transactions

Robert M. Williams Jr., a Director and 10% Owner of Aveanna Healthcare Holdings, Inc., reported in-kind distributions of common stock from entities he indirectly controls, effective July 10, 2025.

Patrick A. Cunningham, Chief Compliance Officer of Aveanna Healthcare Holdings, Inc., sold 18,500 shares of common stock for approximately $91,173 under a Rule 10b5-1 trading plan.

J.H. Whitney Equity Partners VII, a significant shareholder and director of Aveanna Healthcare Holdings, Inc., reported the sale of 750,000 shares of common stock for approximately $3.9 million under a Rule 10b5-1 trading plan.

Paul R. Vigano, a Director and 10% owner of Aveanna Healthcare Holdings, Inc., reported the sale of 750,000 shares of common stock at $5.20 per share.

Robert M. Williams Jr., a Director and 10% Owner of Aveanna Healthcare Holdings, Inc., reported the sale of 750,000 shares of common stock at $5.20 per share.

Aveanna Healthcare Holdings, Inc.'s Chief Financial Officer, Matthew Buckhalter, sold 11,188 shares of common stock for approximately $5.72 per share on June 10, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Deborah Stewart, Senior Vice President and Chief Accounting Officer of Aveanna Healthcare Holdings, Inc. (AVAH), reported the sale of 15,457 shares of common stock.

Jerry Perchik, Chief Legal Officer of Aveanna Healthcare Holdings, Inc., acquired 139,665 shares of common stock through the vesting of performance-based restricted stock units.

Aveanna Healthcare Holdings, Inc.'s Chief Administrative Officer, Edwin C. Reisz, reported the vesting of 139,665 performance-based restricted stock units and the subsequent withholding of 49,783 shares for tax purposes.

Aveanna Healthcare Holdings, Inc. CEO Jeff Shaner reported the vesting of performance-based restricted stock units, resulting in the acquisition of 139,665 shares and the disposition of 63,618 shares for tax purposes on June 5, 2025.

Aveanna Healthcare Holdings, Inc.'s Chief Financial Officer, Matthew Buckhalter, acquired 139,665 shares of common stock through the vesting of performance-based restricted stock units, while 51,298 shares were withheld for tax purposes.

Patrick A. Cunningham, Chief Compliance Officer of Aveanna Healthcare Holdings, Inc., reported the vesting of 139,665 performance-based restricted stock units and the subsequent disposition of 45,759 shares for tax purposes, resulting in a net increase of 93,906 shares in his beneficial ownership.

Deborah Stewart, SVP and Chief Accounting Officer of Aveanna Healthcare Holdings, Inc., reported the vesting of performance-based restricted stock units and subsequent tax-related share withholding.

J.H. Whitney Equity Partners VII, LLC, a 10% owner of Aveanna Healthcare Holdings, Inc., reports the disposition of common stock and adjustments to its beneficial ownership.

Robert M. Williams Jr., a director of Aveanna Healthcare Holdings, Inc., reports a disposition of shares and beneficial ownership details.

Paul R. Vigano, a director of Aveanna Healthcare Holdings, indirectly disposed of shares at $5.36 per share.

Robert M. Williams Jr., a director of Aveanna Healthcare Holdings, reported the sale of common stock through a pre-arranged 10b5-1 trading plan.

J.H. Whitney Equity Partners VII, LLC reports the sale of Aveanna Healthcare Holdings, Inc. shares through a pre-arranged Rule 10b5-1 trading plan.

Paul R. Vigano, a director of Aveanna Healthcare Holdings, reported the sale of common stock held indirectly through various entities, executed under a pre-arranged 10b5-1 trading plan.

J.H. Whitney Equity Partners VII, LLC reports the sale of Aveanna Healthcare Holdings shares through a pre-arranged Rule 10b5-1 trading plan.

Paul Vigano, a director and related to significant shareholders of Aveanna Healthcare Holdings, reported the sale of common stock under a pre-arranged 10b5-1 trading plan.

Robert M. Williams Jr., a director of Aveanna Healthcare Holdings, reported the sale of common stock through entities associated with J.H. Whitney Capital Partners, LLC, under a pre-arranged trading plan.

Robert M. Williams Jr., a director of Aveanna Healthcare Holdings, reported sales of common stock executed under a pre-arranged Rule 10b5-1 trading plan.

Paul R. Vigano, a director of Aveanna Healthcare Holdings, reported the sale of common stock through entities associated with J.H. Whitney Capital Partners, LLC, under a pre-arranged 10b5-1 trading plan.

J.H. Whitney Equity Partners VII, LLC reports the sale of Aveanna Healthcare Holdings, Inc. shares held by related entities under a pre-arranged Rule 10b5-1 trading plan.

J.H. Whitney Equity Partners VII, LLC reports the sale of Aveanna Healthcare Holdings, Inc. shares through a pre-arranged Rule 10b5-1 trading plan.

Robert M. Williams Jr., a director of Aveanna Healthcare Holdings, reported the sale of common stock indirectly through affiliated entities under a pre-arranged 10b5-1 trading plan.

Paul R. Vigano, a director indirectly associated with major shareholders of Aveanna Healthcare Holdings, reports sales of common stock under a pre-arranged Rule 10b5-1 trading plan.

J.H. Whitney Equity Partners VII, LLC, a 10% owner of Aveanna Healthcare Holdings, Inc., reported the sale of common stock through a pre-arranged Rule 10b5-1 trading plan.

Robert M. Williams Jr., a director at Aveanna Healthcare Holdings, reported the sale of common stock through a pre-arranged Rule 10b5-1 trading plan.